Affordable Access

deepdyve-link
Publisher Website

Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients.

Authors
  • Lin, Jian-Xian1
  • Tang, Yi-Hui1
  • Wang, Jia-Bin1
  • Lu, Jun1
  • Chen, Qi-Yue1
  • Cao, Long-Long1
  • Lin, Mi1
  • Tu, Ru-Hong1
  • Huang, Chang-Ming1
  • Li, Ping1
  • Zheng, Chao-Hui1
  • Xie, Jian-Wei2
  • 1 Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian Province, China. , (China)
  • 2 Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian Province, China. [email protected] , (China)
Type
Published Article
Journal
World journal of gastroenterology
Publication Date
Nov 07, 2019
Volume
25
Issue
41
Pages
6258–6272
Identifiers
DOI: 10.3748/wjg.v25.i41.6258
PMID: 31749596
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Increasing numbers of laboratory blood parameters (BPM) have been reported to greatly affect the long-term outcomes of gastric cancer (GC) patients. However, the existing prognostic models do not comprehensively analyze these predictors. To construct a new prognostic tool, based on all the prognostic BPM, to achieve more accurate prognosis prediction for GC. We retrospectively assessed 850 consecutive patients who underwent curative resection for stage II-III GC from January 2010 to April 2013. The patients were classified into developing (n = 567) and validation (n = 283) cohorts using computer-generated random numbers. A scoring system, namely BPM score, was then constructed using least absolute shrinkage and selection operator (LASSO) Cox regression model in the developing cohort, and validated in the validation cohort. A nomogram consisting of BPM score and tumor-lymph node-metastasis (TNM) stage was further created. The discrimination and calibration of the nomogram were evaluated via Harrell's C-statistic and the Hosmer-Lemeshow test. Using the LASSO model, we established the BPM score based on five BPM: Albumin, lymphocyte-to-monocyte ratio, neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 19-9. The BPM scores were divided into high- and low-BPM groups based on a cut-off value of -0.93. High-BPM patients were significantly older and had more advanced, larger tumors. In the developing cohort, significant differences were found in 5-year overall survival (OS) and 5-year disease-specific survival between the high-BPM and low-BPM patients. Similar results were found in the validation group. Multivariable analysis showed that the BPM score was an independent predictor of OS. High-BPM patients had a poorer 5-year OS for each subgroup. Furthermore, a nomogram that combined the BPM score and TNM stage had significantly better prognostic value compared with TNM stage alone. The BPM score provides more accurate prognosis prediction in stage II-III GC patients and is an effective complement to the TNM staging system. ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.

Report this publication

Statistics

Seen <100 times